TME-SW
01698
XIAOMI-W
01810
TRIP.COM-S
09961
BIDU-SW
09888
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -38.10%196.64M | ---- | 101.14%317.66M | ---- | 96.81%157.93M | ---- | -94.91%80.24M | ---- | 289.06%1.58B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -318.95%-6.46M | ---- | 21.70%-1.54M | ---- | -207.98%-1.97M | ---- | 71.76%-639K | ---- | 37.91%-2.26M |
Interest expense - adjustment | ---- | 42.58%55.02M | ---- | 51.48%38.59M | ---- | 42.11%25.48M | ---- | 35.68%17.93M | ---- | 17.92%13.21M |
Attributable subsidiary (profit) loss | ---- | 25.90%-146.11M | ---- | 6.29%-197.18M | ---- | -8,367.44%-210.42M | ---- | -113.78%-2.49M | ---- | -54.75%18.03M |
Impairment and provisions: | ---- | 526.49%246.16M | ---- | 7.53%39.29M | ---- | 5,611.61%36.54M | ---- | -101.76%-663K | ---- | 23.09%37.66M |
-Impairmen of inventory (reversal) | ---- | 515.69%636K | ---- | ---153K | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | 486.11%210.68M | ---- | -1.63%35.95M | ---- | --36.54M | ---- | ---- | ---- | 23.09%37.66M |
-Impairment of goodwill | ---- | --34.85M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | --3.5M | ---- | ---- | ---- | ---663K | ---- | ---- |
Revaluation surplus: | ---- | ---- | ---- | -119.47%-248K | ---- | 158.98%1.27M | ---- | -53,900.00%-2.16M | ---- | -100.13%-4K |
-Other fair value changes | ---- | ---- | ---- | -119.47%-248K | ---- | 158.98%1.27M | ---- | -53,900.00%-2.16M | ---- | -100.13%-4K |
Asset sale loss (gain): | ---- | -46.34%-319.86M | ---- | -4,206.16%-218.57M | ---- | 108.11%5.32M | ---- | 95.13%-65.67M | ---- | -2,543,796.23%-1.35B |
-Loss (gain) from sale of subsidiary company | ---- | -41.75%-312.18M | ---- | -4,237.42%-220.24M | ---- | 108.11%5.32M | ---- | 95.13%-65.67M | ---- | ---1.35B |
-Loss (gain) on sale of property, machinery and equipment | ---- | -561.48%-7.68M | ---- | --1.66M | ---- | ---- | ---- | ---- | ---- | 416.98%274K |
Depreciation and amortization: | ---- | 42.97%39.24M | ---- | 87.20%27.44M | ---- | 26.78%14.66M | ---- | -57.98%11.56M | ---- | -5.74%27.52M |
-Depreciation | ---- | 42.97%39.24M | ---- | 87.20%27.44M | ---- | 26.78%14.66M | ---- | -57.98%11.56M | ---- | -5.74%27.52M |
Exchange Loss (gain) | ---- | 69.22%-1.16M | ---- | -380.56%-3.78M | ---- | -406.23%-787K | ---- | 1,217.39%257K | ---- | -103.08%-23K |
Special items | ---- | -775.21%-7.19M | ---- | 193.18%1.07M | ---- | -225.33%-1.14M | ---- | -82.60%912K | ---- | --5.24M |
Operating profit before the change of operating capital | ---- | 1,966.43%56.27M | ---- | -89.87%2.72M | ---- | -31.55%26.89M | ---- | -87.99%39.28M | ---- | -36.62%327.16M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -12.57%4.18M | ---- | 1,914.77%4.78M | ---- | -82.74%237K | ---- | 101.85%1.37M | ---- | 6.36%-74.14M |
Accounts receivable (increase)decrease | ---- | -1,324.66%-57.61M | ---- | -87.24%4.7M | ---- | 129.05%36.87M | ---- | 64.78%-126.91M | ---- | -14.62%-360.3M |
Accounts payable increase (decrease) | ---- | -307.90%-31.42M | ---- | -10.50%15.11M | ---- | 800.16%16.89M | ---- | 104.82%1.88M | ---- | -130.50%-38.93M |
prepayments (increase)decrease | ---- | -389.52%-96.6M | ---- | 252.09%33.37M | ---- | -219.54%-21.94M | ---- | 131.82%18.35M | ---- | 11.59%-57.67M |
Special items for working capital changes | ---- | -151.71%-363K | ---- | 2,293.75%702K | ---- | -540.00%-32K | ---- | 99.99%-5K | ---- | ---68.33M |
Cash from business operations | ---- | -304.53%-125.55M | ---- | 4.18%61.38M | ---- | 189.22%58.92M | ---- | 75.74%-66.03M | ---- | -247.05%-272.2M |
Other taxs | ---- | -19.08%-8.88M | ---- | 9.91%-7.46M | ---- | 71.71%-8.28M | ---- | 52.14%-29.28M | ---- | 30.11%-61.17M |
Special items of business | 263.81%155.03M | ---- | -195.33%-94.64M | ---- | 2,640.81%99.27M | ---- | 103.00%3.62M | ---- | 54.19%-120.73M | ---- |
Net cash from operations | 263.81%155.03M | -349.30%-134.43M | -195.33%-94.64M | 6.49%53.92M | 2,640.81%99.27M | 153.13%50.64M | 103.00%3.62M | 71.41%-95.31M | 54.19%-120.73M | -441.63%-333.38M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 318.95%6.46M | ---- | -21.70%1.54M | ---- | 207.98%1.97M | ---- | -71.76%639K | ---- | -37.91%2.26M |
Dividend received - investment | ---- | 83.92%94.52M | ---- | 24.65%51.39M | ---- | 53.52%41.23M | ---- | 106.13%26.86M | ---- | ---438.03M |
Decrease in deposits (increase) | ---- | 58.68%-100K | ---- | -102.16%-242K | ---- | 201.80%11.2M | ---- | -319.08%-11M | ---- | 199.19%5.02M |
Sale of fixed assets | ---- | -67.59%9.02M | ---- | 11,687.29%27.82M | ---- | 3,271.43%236K | ---- | --7K | ---- | ---- |
Purchase of fixed assets | ---- | 16.49%-29.62M | ---- | 6.49%-35.47M | ---- | 59.03%-37.93M | ---- | -70.74%-92.6M | ---- | -59.48%-54.24M |
Purchase of intangible assets | ---- | ---29.57M | ---- | ---- | ---- | -130.46%-696K | ---- | 53.96%-302K | ---- | -19.06%-656K |
Sale of subsidiaries | ---- | --220.37M | ---- | ---- | ---- | ---- | ---- | --30M | ---- | ---- |
Acquisition of subsidiaries | ---- | 78.36%-18M | ---- | -12,086.46%-83.19M | ---- | --694K | ---- | ---- | ---- | 84.45%-327K |
Recovery of cash from investments | ---- | 811.31%45.68M | ---- | --5.01M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | ---- | 24.44%-72.02M | ---- | 63.47%-95.31M | ---- | -347.15%-260.93M | ---- | -815.34%-58.35M | ---- | 86.28%-6.38M |
Other items in the investment business | -166.26%-189.61M | 3,235.42%46.12M | 834.92%286.16M | -117.93%-1.47M | 47.37%-38.94M | 127.29%8.21M | -1,270.94%-73.98M | -9.89%3.61M | 38.33%-5.4M | -64.57%4.01M |
Net cash from investment operations | -166.26%-189.61M | 310.04%272.86M | 834.92%286.16M | 44.96%-129.91M | 47.37%-38.94M | -133.36%-236.03M | -1,270.94%-73.98M | 79.29%-101.14M | 38.33%-5.4M | -567.99%-488.34M |
Net cash before financing | -118.06%-34.58M | 282.17%138.43M | 217.42%191.52M | 59.01%-75.99M | 185.76%60.34M | 5.63%-185.39M | 44.22%-70.35M | 76.09%-196.45M | 53.68%-126.12M | -3,457.08%-821.71M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | 4.37%869.92M | ---- | 268.76%833.47M | ---- | 6.32%226.02M | ---- | -58.86%212.58M | ---- | 135.21%516.76M |
Refund | ---- | -56.72%-927.57M | ---- | -631.59%-591.85M | ---- | -161.47%-80.9M | ---- | 85.31%-30.94M | ---- | 2.05%-210.59M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | --56.87M | ---- | ---- | ---- | ---- |
Interest paid - financing | ---- | -19.54%-56.98M | ---- | -53.08%-47.66M | ---- | -124.56%-31.14M | ---- | -54.30%-13.87M | ---- | 19.80%-8.99M |
Dividends paid - financing | ---- | ---70.52M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.57%846K |
Other items of the financing business | 217.23%54.13M | -195.53%-9.5M | -33.93%-46.17M | 1,070.24%9.95M | -132.57%-34.48M | 29.21%-1.03M | -1.01%105.86M | -170.36%-1.45M | 8.53%106.95M | 2,609.76%2.06M |
Net cash from financing operations | 217.23%54.13M | -204.12%-210.98M | -33.93%-46.17M | 20.98%202.64M | -132.57%-34.48M | 5.10%167.49M | -1.01%105.86M | -45.59%159.36M | 8.53%106.95M | 40,550.41%292.86M |
Effect of rate | 104.28%116K | 22.76%1.36M | -1.69%-2.71M | 688.83%1.11M | -1,249.14%-2.67M | 86.50%-188K | -80.71%232K | -252.24%-1.39M | -74.08%1.2M | -62.80%915K |
Net Cash | -86.55%19.55M | -157.29%-72.56M | 462.07%145.35M | 807.58%126.65M | -27.18%25.86M | 51.75%-17.9M | 285.20%35.51M | 92.99%-37.1M | 88.97%-19.17M | -2,326.46%-528.85M |
Begining period cash | -31.27%156.49M | 127.84%227.69M | 127.84%227.69M | -15.33%99.93M | -15.33%99.93M | -24.59%118.02M | -24.59%118.02M | -77.13%156.51M | -77.13%156.51M | 3.98%684.45M |
Cash at the end | -52.43%176.16M | -31.27%156.49M | 200.77%370.33M | 127.84%227.69M | -19.92%123.13M | -15.33%99.93M | 10.99%153.76M | -24.59%118.02M | -73.12%138.54M | -77.13%156.51M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.